<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001085'>Papilledema</z:hpo> from benign intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> can cause severe loss of visual acuity and visual field, with an <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We report a study of 5 patients with benign intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, and severe <z:hpo ids='HP_0000572'>visual loss</z:hpo> (visual field loss and visual acuity reduced to 1/10 or less) not improved by medical therapy (<z:chebi fb="0" ids="27690">acetazolamide</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>We performed unilateral orbital decompression of the optic nerve sheath </plain></SENT>
<SENT sid="3" pm="."><plain>No major operative complication was noted </plain></SENT>
<SENT sid="4" pm="."><plain>Follow-up ranged from 11 months to 23 months, with an average of sixteen months </plain></SENT>
<SENT sid="5" pm="."><plain>Visual function improvement was noted within 3 months after operation in 4 patients (for 2 eyes on the surgical side improvement of 2/10 and 5/10, for 3 eyes on the opposite surgical side average improvement of 4.6/10) </plain></SENT>
<SENT sid="6" pm="."><plain>The other patient showed improvement, but no significant </plain></SENT>
<SENT sid="7" pm="."><plain>Optic nerve sheath decompression in benign intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> seems to be a safe procedure and a therapeutic option in the management of <z:e sem="disease" ids="C0151740" disease_type="Disease or Syndrome" abbrv="">raised intracranial pressure</z:e> complicated by <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> with severe <z:hpo ids='HP_0000572'>visual loss</z:hpo> </plain></SENT>
</text></document>